본문 바로가기
bar_progress

Text Size

Close

Phase 3 Clinical Approval! Full Government Budget Support! Golden Beneficiary Stocks Revealed!

Did you see ‘Humasis (205470)’ that you applied for?

Congratulations to everyone who applied for the free trial. We keep receiving thank-you messages.

▶Next limit-up follow-up stocks will be released on a first-come, first-served basis. This time, it will definitely explode by 500%. [Check the stocks]


* It’s okay if you applied late. We will release it once again.

▶▶ Immediately ‘2 consecutive limit-ups’ will hit for COVID-19 treatment Phase 3 clinical trial + government-supported great success!! Related stocks! [Click]


"This company" supplies synthetic services used in the development and production stages of mRNA vaccines! With the increase in demand for mRNA, plasma treatments, and cold chain due to COVID-19, sales are skyrocketing! Providing 'mRNA vaccine services' for the commercialization of Pfizer and Moderna vaccines, "this company" is expected to rise over 1000%. You can check "this company" at the link!


Following the success of Phase 3 clinical trials, “ㅇㅇㅇ” receives full budget support from the Ministry of Health and Welfare!

Tomorrow will be too late! Institutional accumulation is already complete! As an undervalued bottom stock, the price will soon explode.


▶▶ It will go straight to ‘2 consecutive limit-ups’. COVID-19 vaccine Phase 3 clinical trial success!! Beneficiary stocks! Don’t miss out. [COVID vaccine Phase 3 clinical trial success! “ㅇㅇㅇ” related stocks, apply now]


"I applied for the free trial and followed it consistently for 3 days, and it was really amazing to see limit-up profits every day. When I was doing it alone, hitting the limit-up was so difficult, but after tasting it daily, I couldn’t stop, so I immediately paid the membership fee and am receiving VIP service. Considering the low membership fee, I am just grateful that I earn more every day. It’s already been 5 months since I started properly, and I have accumulated 62 million KRW. Thank you so much." (VIP office worker Kim Suhyun, 37 years old)


Think of this as the last chance. You must seize the opportunity when it comes.

It will explode exactly on “September 24”! Don’t miss it and regret it, and buy at least 1 million KRW worth!


[Recent AI limit-up hits]

*21.09.17 Kolon Plastics (138490) limit-up hit!

*21.09.10 Amosense (357580) limit-up hit!

*21.09.03 Phoenix Materials (050090) limit-up hit!

*21.08.23 Kukje Pharm (002720) limit-up hit!

*21.08.17 Seorin Bio (038070) limit-up hit!

*21.08.12 Wonbang Tech (053080) limit-up hit!

*21.08.10 SK Bioscience (302440) limit-up hit!

*21.08.09 Sejin TS (067770) limit-up hit!

*21.08.06 Galaxia SM (011420) limit-up hit!

*21.08.03 SM C&C (048550) limit-up hit!

*21.07.28 Next Science (003580) limit-up hit!

*21.07.23 Sejong Medical (258830) limit-up hit!

*21.07.21 Innodep (303530) limit-up hit!

*21.07.19 A-Root (096690) limit-up hit!

*21.07.16 Iljin Electric (103590) limit-up hit!

*21.07.12 P&C Tech (237750) limit-up hit!

*21.07.08 PHC (057880) limit-up hit!

*21.07.05 Korea BNC (256840) limit-up hit!

*21.07.01 Il Sung Construction (022220) limit-up hit!

*21.06.28 PHC (057880) limit-up hit!

*21.06.21 Hanse MK (069640) limit-up hit!

*21.06.17 Jungwon Ensis (045510) limit-up hit!

*21.06.11 Peace Industry (090080) limit-up hit!

*21.06.07 BHI (083650) limit-up hit!

*21.06.02 Nature & Environment (043910) limit-up hit!

*21.05.28 Samsung Pharm (001360) limit-up hit!

*21.05.24 Sunic System (171090) limit-up hit!

*21.05.17 Ilyeon Pharm (102460) limit-up hit!

*21.05.11 Bio Leaders (142760) limit-up hit!

*21.05.07 Samsung Pharm (001360) limit-up hit!

*21.05.03 SJM Holdings (025530) limit-up hit!


* “VVIP accumulation limit-up” that will explode soon is provided to 30 people and then closed.

Please understand that early closure occurs due to overwhelming applications and volume management.


[Today’s stocks of interest]

Humasis Gold Pacific SD Biosensor PharmGen Science GtreeBNT


※ This content is unrelated to the editorial direction of Asia Economy, and all responsibility lies with the information provider.


© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Special Coverage


Join us on social!

Top